Passage Bio stockholders elect two directors, ratify KPMG, authorize reverse stock split

Passage BIO, Inc.

Maxine Gowen, Ph.D. and Dolan Sondhi, Ph.D. elected as Class II directors for three-year terms.
Ratification of KPMG LLP as independent auditor for FY 2025 with 49.46M shares for, 70.7K against.
Approval granted for Board to implement reverse stock split at ratio 1:5 to 1:50, by Dec 31, 2025.
No broker non-votes on proposals 2 and 3; 13.59M broker non-votes on director election.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.